This could be addressed in future studies that will follow NK cell functionality and tumor growth in reovirus-treated cancer patients, in addition to testing the expression of NKG2D ligands in tumor biopsies prior to and following reovirus treatment. Here, KLRK1 is linked to neoplasm.